Matsuda et al., 1998 - Google Patents
Immunosuppressants decrease neutrophil chemoattractant and attenuate ischemia/reperfusion injury of the liver in ratsMatsuda et al., 1998
- Document ID
- 1770102654128143369
- Author
- Matsuda T
- Yamaguchi Y
- Matsumura F
- Akizuki E
- Okabe K
- Liang J
- Ohshiro H
- Ichiguchi O
- Yamada S
- Mori K
- Ogawa M
- Publication year
- Publication venue
- Journal of Trauma and Acute Care Surgery
External Links
Snippet
Background Neutrophils may play an important role in the development of liver ischemia/reperfusion injury. We investigated the effects of the immunosuppressants azathioprine (AZA), cyclosporine A (CsA), tacrolimus (FK506), and rapamycin (RPM) on the …
- 210000004185 Liver 0 title abstract description 62
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Matsuda et al. | Immunosuppressants decrease neutrophil chemoattractant and attenuate ischemia/reperfusion injury of the liver in rats | |
| Préville et al. | Mechanisms Involved in Antithymocyte Globulin Immunosuppressive Activity in a Nonhuman Primate Model 1 | |
| Nemoto et al. | Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure | |
| Adams et al. | HEPATIC EXPRESSION OF MACROPHAGE INFLAMMATORY PROTEIN-1α AND MACROPHAGE INFLAMMATORY PROTEIN-1β AFTER LIVER TRANSPLANTATION1 | |
| Mosher et al. | Inhibition of Kupffer cells reduced CXC chemokine production and liver injury | |
| Shirasugi et al. | Up-regulation of oxygen-derived free radicals by interleukin-1 in hepatic ischemia/reperfusion injury1 | |
| Shoup et al. | Mechanisms of neutropenia involving myeloid maturation arrest in burn sepsis | |
| May et al. | Urokinase receptor surface expression regulates monocyte adhesion in acute myocardial infarction | |
| Millan et al. | HUMAN MONOCYTES ACTIVATE PORCINE ENDOTHELIAL CELLS, RESULTING IN INCREASED E-SELECTIN, INTERLEUKIN-8, MONOCYTE CHEMOTACTIC PROTEIN-1, AND PLASMINOGEN ACTIVATOR INHIBITOR-TYPE-1 EXPRESSION1 | |
| Murata et al. | Platelets promote liver regeneration under conditions of Kupffer cell depletion after hepatectomy in mice | |
| Chappell et al. | In vivo visualization of the effect of polyclonal antithymocyte globulins on the microcirculation after ischemia/reperfusion in a primate model | |
| van Rossum et al. | Pharmacodynamic monitoring of calcineurin inhibition therapy: principles, performance, and perspectives | |
| Beiras-Fernandez et al. | Influence of polyclonal anti-thymocyte globulins upon ischemia–reperfusion injury in a non-human primate model | |
| Luyendyk et al. | Coagulation-mediated hypoxia and neutrophil-dependent hepatic injury in rats given lipopolysaccharide and ranitidine | |
| Moriga et al. | Protection by vascular endothelial growth factor against sinusoidal endothelial damage and apoptosis induced by cold preservation | |
| Nikolaeva et al. | Rapamycin does not induce anergy but inhibits expansion and differentiation of alloreactive human T cells | |
| Kinoshita et al. | Opposite effects of enhanced tumor necrosis factor-α production from Kupffer cells by gadolinium chloride on liver injury/mortality in endotoxemia of normal and partially hepatectomized mice | |
| Delbridge et al. | Reduction of ischemia–reperfusion injury in the rat kidney by FTY720, a synthetic derivative of sphingosine | |
| Gummert et al. | PHARMACODYNAMICS OF MYCOPHENOLIC ACID IN HEART ALLOGRAFT RECIPIENTS: CORRELATION OF LYMPHOCYTE PROLIFERATION AND ACTIVATION WITH PHARMACOKINETICS AND GRAFT HISTOLOGY1 | |
| Genduso et al. | Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo | |
| Lim et al. | Activation of mouse protease‐activated receptor‐2 induces lymphocyte adhesion and generation of reactive oxygen species | |
| Moore et al. | Impact of CXCR4/CXCL12 blockade on normal plasma cells in vivo | |
| Tan et al. | Evaluation of the role of P-glycoprotein in inflammation induced blood–brain barrier damage | |
| Zhang et al. | Acute cellular rejection predominated by monocytes is a severe form of rejection in human renal recipients with or without campath‐1H (Alemtuzumab) induction therapy | |
| Morita et al. | Activated Kupffer cells play an important role in intra-hepatic Th1-associated necro-inflammation in Concanavalin A-induced hepatic injury in mice |